Skip to main content

Table 2 Factors associated with uptake of optimal doses of IPTp among women aged 15–49 years who had a live birth within 2 years preceding the survey, UDHS 2016

From: Factors associated with uptake of optimal doses of intermittent preventive treatment for malaria among pregnant women in Uganda: analysis of data from the Uganda Demographic and Health Survey, 2016

Characteristic

< 3 doses

≥ 3 doses

cOR (95% CI)

p-value

aOR (95% CI)

p-value

Age group (years)

 15–24

2020

491

Reference

 

Reference

 

 25–34

2036

437

0.88 (0.75–1.03)

0.12

0.91 (0.77–1.07)

0.25

 > 34

796

121

0.63 (0.49–0.81)*

< 0.01

0.70 (0.53–0.92)**

0.01

Education

 Higher education

369

63

Reference

 

Reference

 

 Secondary

1045

280

1.56 (1.12–2.18)*

0.008

1.50 (1.04–2.15)**

0.028

 Primary

2956

622

1.23 (0.89–1.70)

0.86

1.27 (0.88–1.81)

0.20

 No education

483

83

1.00 (0.68–1.47)

0.99

1.42 (0.93–2.17)

0.11

Marital status

 Never married

297

74

Reference

   

 Married

4090

882

0.87 (0.62–1.22)

0.42

  

 Separated

465

93

0.81 (0.53–1.24)

0.34

  

Residence

 Urban

1050

208

Reference

   

 Rural

3803

840

1.11 (0.90–1.38)

0.33

  

Wealth

 Poorest

1123

202

Reference

 

Reference

 

 Poorer

1017

236

1.29 (1.05–1.57)*

0.015

1.16 (0.93–1.44)

0.19

 Middle

903

217

1.33 (1.06–1.67)*

0.013

1.20 (0.93–1.54)

0.17

 Richer

840

197

1.30 (1.04–1.63)*

0.022

1.10 (0.85–1.42)

0.47

 Richest

970

196

1.12 (0.87–1.45)

0.38

1.02 (0.74–1.40)

0.92

Region of residence

 Kampala

200

36

Reference

 

Reference

 

 Central

1113

253

1.27 (0.84–1.92)

0.26

1.23 (0.78–1.94)

0.38

 Busoga

450

130

1.61 (1.01–2.57)*

0.046

1.55 (0.93–2.58)

0.092

 Bugishu

319

77

1.35 (0.85–2.15)

0.20

1.27 (0.76–2.15)

0.36

 Acholi

249

51

1.14 (0.70–1.85)

0.60

1.20 (0.69–2.09)

0.52

 West Nile

353

59

0.93 (0.58–1.48)

0.75

0.93 (0.55–1.56)

0.77

 Bukedi

153

15

0.54 (0.28–1.06)

0.073

0.56 (0.26–1.21)

0.14

 Lango

234

68

1.62 (0.98–2.66)

0.058

1.73 (1.01–2.96)**

0.046

 Karamoja

235

47

1.12 (0.68–1.84)

0.65

1.20 (0.69–2.10)

0.52

 Teso

338

82

1.36 (0.83–2.21)

0.22

1.35 (0.78–2.34)

0.28

 Bunyoro/Toro

657

143

1.21 (0.81–1.83)

0.35

1.19 (0.75–1.89)

0.46

 Ankole/Kigezi

551

88

0.89 (0.57–1.41)

0.62

0.83 (0.51–1.38)

0.48

Parity

 1 child

1091

247

Reference

   

 2 children

878

230

1.15 (0.92–1.45)

0.92

  

 3+ children

2883

572

0.88 (0.74–1.04)

0.74

  

Number of ANC visits

 < 4 times

1898

331

Reference

 

Reference

 

 ≥ 4 times

2845

709

1.43 (1.22–1.69)*

< 0.01

1.34 (1.12–1.60)**

0.001

 Unknown

109

9

0.46 (0.20–1.07)

0.07

  

Source of antimalarial

 ANC

3517

1023

Reference

   

 Other facility visit

52

18

1.19 (0.65–2.17)

0.57

  

 Other sources

13

7

1.86 (0.69–4.99)

0.22

  

 Unknown

1271

0

  

Timing of ANC visit

 1st trimester

1386

305

Reference

 

Reference

 

 2nd trimester

2929

693

1.07 (0.90–1.28)

0.42

1.13 (0.93–1.36)

0.22

 3rd trimester

428

45

0.48 (0.32–0.70)*

< 0.01

0.58 (0.38–0.87)**

0.009

Listen to radio

 Not at all

1365

259

Reference

 

Reference

 

 < Once a week

748

142

1.00 (0.76–1.32)

0.99

1.05 (0.79–1.40)

0.73

 ≥ Once a week

2739

648

1.25 (1.05–1.49)*

0.013

1.23 (1.02–1.48)**

0.028

  1. *Significant variables at the bivariate analysis
  2. **Significant variables at the multivariate logistic regression